These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 22623122)

  • 1. Treatment experience, burden and unmet needs (TRIBUNE) in MS study: results from five European countries.
    Karampampa K; Gustavsson A; Miltenburger C; Eckert B
    Mult Scler; 2012 Jun; 18(2 Suppl):7-15. PubMed ID: 22623122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment experience, burden, and unmet needs (TRIBUNE) in Multiple Sclerosis study: the costs and utilities of MS patients in The Netherlands.
    Karampampa K; Gustavsson A; van Munster ET; Hupperts RM; Sanders EA; Mostert J; Sinnige OL; de Graaf J; Pop P; Miltenburger C; Groot MT; Relleke M; van der Hel WS
    J Med Econ; 2013 Jul; 16(7):939-50. PubMed ID: 23692584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Costs and quality of life of multiple sclerosis in Italy.
    Kobelt G; Berg J; Lindgren P; Battaglia M; Lucioni C; Uccelli A
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S45-54. PubMed ID: 17310336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costs and quality of life of multiple sclerosis in Switzerland.
    Kobelt G; Berg J; Lindgren P; Gerfin A; Lutz J
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S86-95. PubMed ID: 17310338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costs and quality of life of multiple sclerosis in Austria.
    Kobelt G; Berg J; Lindgren P; Plesnilla C; Baumhackl U; Berger T; Kolleger H; Vass K
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S14-23. PubMed ID: 17310339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costs and quality of life of multiple sclerosis in Sweden.
    Berg J; Lindgren P; Fredrikson S; Kobelt G
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S75-85. PubMed ID: 17310342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costs and quality of life in multiple sclerosis in The Netherlands.
    Kobelt G; Berg J; Lindgren P; Anten B; Ekman M; Jongen PJ; Polman C; Uitdehaag B
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S55-64. PubMed ID: 17310343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Costs and quality of life of multiple sclerosis in Germany.
    Kobelt G; Berg J; Lindgren P; Elias WG; Flachenecker P; Freidel M; König N; Limmroth V; Straube E
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S34-44. PubMed ID: 17310337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costs and quality of life for patients with multiple sclerosis in Belgium.
    Kobelt G
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S24-33. PubMed ID: 17318662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Costs and quality of life of multiple sclerosis in Spain.
    Kobelt G; Berg J; Lindgren P; Izquierdo G; Sánchez-Soliño O; Pérez-Miranda J; Casado MA;
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S65-74. PubMed ID: 17310340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Burden of illness in multiple sclerosis (DEFENSE) study: the costs and quality-of-life of Finnish patients with multiple sclerosis.
    Ruutiainen J; Viita AM; Hahl J; Sundell J; Nissinen H
    J Med Econ; 2016; 19(1):21-33. PubMed ID: 26360615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment experience, burden, and unmet needs (TRIBUNE) in multiple sclerosis: the costs and utilities of MS patients in Canada.
    Karampampa K; Gustavsson A; Miltenburger C; Kindundu CM; Selchen DH
    J Popul Ther Clin Pharmacol; 2012; 19(1):e11-25. PubMed ID: 22247419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment experience, burden and unmet needs (TRIBUNE) in MS study: results from Turkey.
    Karabudak R; Karampampa K; Calışkan Z;
    J Med Econ; 2015 Jan; 18(1):69-75. PubMed ID: 25116693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct and indirect economic consequences of multiple sclerosis in Ireland.
    Fogarty E; Walsh C; McGuigan C; Tubridy N; Barry M
    Appl Health Econ Health Policy; 2014 Dec; 12(6):635-45. PubMed ID: 25227118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costs and quality of life of multiple sclerosis in the United Kingdom.
    Kobelt G; Berg J; Lindgren P; Kerrigan J; Russell N; Nixon R
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S96-104. PubMed ID: 17310341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The long-term cost of multiple sclerosis in France and potential changes with disease-modifying interventions.
    Kobelt G; Texier-Richard B; Lindgren P
    Mult Scler; 2009 Jun; 15(6):741-51. PubMed ID: 19383645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Costs and quality of life in multiple sclerosis in Europe: method of assessment and analysis.
    Kobelt G; Berg J; Lindgren P; Jönsson B
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S5-13. PubMed ID: 17310344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost analysis of multiple sclerosis in Brazil: a cross-sectional multicenter study.
    da Silva NL; Takemoto MLS; Damasceno A; Fragoso YD; Finkelsztejn A; Becker J; Gonçalves MVM; Tilbery C; de Oliveira EML; Callegaro D; Boulos FC
    BMC Health Serv Res; 2016 Mar; 16():102. PubMed ID: 27009599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health status and costs of ambulatory patients with multiple sclerosis in Hungary.
    Péntek M; Gulácsi L; Rózsa C; Simó M; Iljicsov A; Komoly S; Brodszky V
    Ideggyogy Sz; 2012 Sep; 65(9-10):316-24. PubMed ID: 23126217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What drives quality of life in multiple sclerosis?
    Hemmett L; Holmes J; Barnes M; Russell N
    QJM; 2004 Oct; 97(10):671-6. PubMed ID: 15367738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.